Inactive Instrument

News Sirona Biochem Corp Toronto S.E.

Equities

SBM

CA82967M1005

Summary

Unlock all the news: Be the first to know and act before the market!

Sirona Biochem Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	21/06	CI
Sirona Biochem Corp. - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report	19/06	AQ
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report	18/06	GL
Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations	18/06	NE
Sirona Biochem Engages Stonegate Healthcare Partners	07/05	CI
Sirona Biochem Engages Stonegate Healthcare Partners	07/05	GL
Sirona Biochem Provides Update on Anti-Aging Product	08/04	MT
SIRONA BIOCHEM Corporate Update April 2024	08/04	GL
SIRONA BIOCHEM Corporate Update April 2024	08/04	AQ
Sirona Biochem Announces Close of Private Placement	05/04	GL
Sirona Biochem Corp. announced that it has received CAD 0.1325 million in funding	04/04	CI
Sirona Biochem Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	01/04	CI
Sirona Biochem Announces 2023 Annual Meeting Results	29/03	GL
Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations	13/03	MT
Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations	13/03	GL
Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations	13/03	AQ
Sirona Biochem Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	29/02	CI
Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025	21/02	GL
Sirona Biochem Provides Update on Loan	16/02	AQ
Sirona Biochem Engages Global Beauty Consulting	15/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sirona Biochem Corp Toronto S.E.

Equities

SBM

CA82967M1005

Summary

Filters